Teva Pharma Industries Ltd ADR (TEVA) Financials

$36.76

$0.40 (1.10%)

As on 08-Sep-2026 16:00EDT

Market cap

$42,673 Mln

Revenue (TTM)

$17,314 Mln

P/E Ratio

61

P/B Ratio

5.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	17,314.00	17,257.00	16,544.00	15,846.00	14,925.00	15,878.00
Cost of Revenue	8,232.00	8,320.00	8,481.00	8,201.00	7,952.00	8,284.00
Gross Profit	9,085.00	8,938.00	8,063.00	7,645.00	6,973.00	7,594.00
Operating Expenses	7,099.00	6,780.00	8,366.00	4,451.00	9,170.00	5,878.00
Operating Profit (EBIT)	1,983.00	2,157.00	-303.00	433.00	-2,197.00	1,716.00
Other Income	--	--	--	--	--	-1,049.00
Profit before Tax	720.00	1,238.00	-1,283.00	-624.00	-3,142.00	667.00
Provision for Tax	12.00	-180.00	676.00	-65.00	-643.00	211.00
Profit after Tax (Net Income)	706.00	1,410.00	-1,639.00	-559.00	-2,446.00	417.00
Minority Interest	-1.00	-7.00	320.00	56.00	53.00	39.00
Consolidated Profit	--	--	--	--	-2,353.00	417.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	7,757.00	7,909.88	5,373.00	7,506.00	7,804.00	10,278.00
Minority Interest	-1.00	--	--	--	--	966.00
Non-Current Liabilities	16,450.00	19,377.70	20,810.00	23,106.00	23,944.00	25,395.00
Current Liabilities	15,646.00	13,455.79	12,796.00	12,247.00	11,469.00	11,027.00
Total Liabilities	55,503.00	40,747.37	39,326.00	43,479.00	44,011.00	47,666.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	26,097.00	26,801.58	26,774.00	30,993.00	31,960.00	35,094.00
Current Assets	13,760.00	13,945.78	12,552.00	12,485.00	12,051.00	12,573.00
Total Assets	55,503.00	40,747.37	39,326.00	43,479.00	44,011.00	47,666.00
Total Debt*	16,874.00	17,381.73	18,079.00	20,153.00	21,561.00	23,459.00
Net Current Assets	-1,886.00	490.00	-244.00	238.00	582.00	1,546.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	1,649.00	1,247.00	1,368.00	1,590.00	798.00
Cash Flow from Investing Activities	--	737.00	792.00	968.00	656.00	1,523.00
Cash from Financing Activities	--	-2,151.00	-1,791.00	-1,913.00	-1,487.00	-2,172.00
Net Cash Inflow / Outflow	--	--	--	--	--	149.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.61	1.20	-1.45	-0.49	-2.20	0.38
Cash EPS ($)	--	2.06	-0.51	0.52	-1.02	1.58
Adjusted Book Value ($)	--	6.74	4.74	6.60	7.02	9.32
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.41	1.10	1.20	1.43	0.72
Free Cash Flow per Share ($)	--	0.98	0.66	0.74	0.94	0.21

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	5.79	-6.41	-1.96	-7.75	1.19
ROE (%)	9.00	21.23	-25.45	-7.30	-27.05	4.11
ROA (%)	1.31	3.52	-3.96	-1.28	-5.34	0.85
EBIT Margin (%)	9.27	12.39	20.38	2.73	-14.96	19.39
Net Margin (%)	4.08	8.17	-9.91	-3.53	-16.39	2.81
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	4.13	0.04	0.04	0.06	-0.06	-0.05
EBIT Growth (%)	-17.94	-36.57	678.75	119.39	-172.52	0.79
Net Profit Growth (%)	560.78	186.03	-193.20	77.15	-686.57	110.45
EPS Growth (%)	505.13	1.83	-1.94	0.78	-6.82	1.10
Book Value Growth (%)	11.70	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	61.03	25.96	-15.24	-21.23	-4.14	21.19
Price / Book Value	5.44	4.63	4.65	1.58	1.30	0.86
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	21.61	16.06	8.97	66.51	-31.23	6.83
Close Price ($)	33.88	31.21	22.04	10.44	9.12	8.01
High Price ($)	37.34	31.99	22.80	11.45	11.34	13.30
Low Price ($)	14.99	12.47	10.45	7.09	6.78	7.73
Market Cap ($ Cr)	42,673.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	1.56	2.20	3.36	2.68	2.76	2.28
Short term debt to equity ratio	0.58	0.23	0.33	0.22	0.27	0.14
Current Ratio	0.88	1.04	0.98	1.02	1.05	1.14
Quick Ratio	0.67	0.80	0.75	0.69	0.72	0.79
Interest Coverage	1.80	2.34	3.58	0.42	-2.40	3.46

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	20.17	21.49	18.49	21.51	24.76	28.52
Asset Turnover	0.32	0.43	0.40	0.36	0.33	0.32
Receivable days	--	71.62	71.39	81.87	100.64	104.78
Inventory Days	--	135.78	151.34	174.90	175.71	181.24
Payable days	--	103.91	103.47	99.96	82.06	75.88
Cash Conversion Cycle	--	103.49	119.26	156.81	194.30	210.14

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.